Medico Remedies Ltd.
Snapshot View

149.00 -0.75 ▼-0.5%

07 October 2022, 12:22:47 PM
Volume: 12,549

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.com
Market Cap 248.79 Cr.
Enterprise Value(EV) 257.06 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.95 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 50.88 Trailing Twelve Months Ending 2022-03
Industry PE 32.07 Trailing Twelve Months Ending 2022-03
Book Value / Share 22.70 Trailing Twelve Months Ending 2022-03
Price to Book Value 6.60 Calculated using Price: 149.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.66 Cr. 16,596,800 Shares
FaceValue 10
Company Profile
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.50%
1 Week
+7.78%
1 Month
+46.65%
3 Month
+68.93%
6 Month
1 Year
2 Year
5 Year
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 9.23 7.14 7.97 10.47 5.67 5.72 5.61 8.31 14.02
Return on Capital Employed (%) 11.37 10.01 10.86 9.39 9.05 7.79 7.66 10.13 15.00
Return on Assets (%) 2.54 2.36 2.78 3.47 2.26 2.31 2.15 3.43 6.44

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 5 9 14 15 16 27 28 30 32 37
Non Curr. Liab. 1 1 1 4 11 3 3 5 5 1
Curr. Liab. 13 22 22 26 21 30 45 40 38 38
Minority Int.
Equity & Liab. 18 31 36 46 48 59 76 75 76 76
Non Curr. Assets 5 8 10 9 10 14 17 19 17 18
Curr. Assets 14 23 26 37 38 46 59 57 58 59
Misc. Exp. not W/O
Total Assets 18 31 36 46 48 59 76 75 76 76

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 34 45 51 67 54 61 98 89 122 121
Other Income 0 0 0 0 0 1 2 2 1 2
Total Income 34 45 51 67 55 62 100 91 123 123
Total Expenditure -32 -43 -48 -63 -50 -58 -95 -86 -117 -114
PBIDT 2 2 3 4 4 4 5 5 6 9
Interest 0 -1 -1 -1 -1 -2 -1 -1 -1 -1
Depreciation 0 -1 -1 -1 -1 -1 -2 -2 -2 -2
Taxation 0 0 0 -1 0 -1 -1 -1 -1 -2
Exceptional Items 0
PAT 0 1 1 1 2 1 2 2 3 5
Adjusted EPS 1 1 1 1 1 1 1 1 2 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 0 -4 -3 5 5 1 -11 2
Cash Fr. Inv. -2 -4 -2 0 -3 -5 -4 -3 -17 -3
Cash Fr. Finan. 0 2 3 2 6 -1 -1 3 18 7
Net Change 0 1 0 -1 0 -1 0 0 -10 6
Cash & Cash Eqvt 0 1 2 1 0 0 0 1 -10 6

Shareholding Pattern View Details >>

9 Qtrs 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34
Public 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 12.94 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of trading window
Medico Remedies Limited has informed the Exchange about Closure of trading window for the quarter and half year ended 30th September, 2022.
Thu, 29 Sep 2022
Closure of trading window
Medico Remedies Limited has informed the Exchange about Closure of trading window for the quarter and half year ended 30th September, 2022.
Thu, 22 Sep 2022
Annual General Meeting
Medico Remedies Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 21-Sep-2022.

Technical Scans View Details >>

Thu, 06 Oct 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at Low Opening at Low
Making Higher Highs for 3 days Making Higher Highs for 3 days

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.90 +0.1%
Divi's Laboratories Ltd. 99,171.10 3,723.80 -0.2%
Cipla Ltd. 91,534.16 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,594.65 -0.6%
Zydus Lifesciences Ltd. 42,831.42 424.50 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 424.50 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 424.50 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 424.50 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 424.50 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 424.50 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 424.50 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.90 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,723.80 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.80 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,391.75 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,387.30 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,594.65 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 424.50 +0.3%

FAQ's On Medico Remedies Ltd.

What is Medico Remedies share price?

Can I buy Medico Remedies shares now?

What is the Market Cap of Medico Remedies?

What are the key metrics to analyse Medico Remedies?

What is the 52 Week High and Low of Medico Remedies?

What is the trend of Medico Remedies share price?